Diabetes, Vol 40, Issue 12 1565-1573, Copyright © 1991 by American Diabetes Association
The pancreatic islet as Rubik's Cube. Is phospholipid hydrolysis a piece of the puzzle?
SA Metz
Department of Medicine, University of Wisconsin School of Medicine, Madison.
At least three types of phospholipase exist in the beta-cells of the
pancreatic islet. Data regarding their physiological activation are
incomplete but suggest that glucose (or its metabolite glyceraldehyde)
either activates or potentiates the activation of several phospholipases.
At least seven phospholipid hydrolysis by-products (diacylglycerol,
myo-inositol 1,4,5-trisphosphate, lysophospholipids, arachidonic acid and
its cyclooxygenase- and lipoxygenase-derived metabolites, phosphatidate)
have been demonstrated to have effects compatible with their postulated
roles as mediators or modulators of islet function. Presumptive mechanisms
of action have been tentatively identified for these metabolites. However,
key studies in the puzzle are missing, and current methodologies have
important limitations. Shortcomings include the paucity of measurements of
the mass of metabolites; the frequent use of static incubations rather than
perfusions; a lack of complete time- and agonist concentration-dependence
curves; the equation of metabolite accumulation with rates of metabolite
generation (which ignores metabolite removal as a key variable); the use of
nonspecific, insensitive, or ambiguous phospholipase assays; and the need
for more studies directly correlating lipid metabolism and insulin
secretion in physiologically functioning preparations. Like Rubik's Cube,
the pancreatic islet is a dynamic puzzle comprised of many interrelated
components requiring proper alignment and integration. Phospholipid
turnover is one "panel" in the islet; however, an obligate role for
phospholipase activation in glucose-induced insulin secretion is not yet
rigorously established, despite tantalizing, inferential evidence. It may
be that glucose serves principally to potentiate the phospholipase and
secretory responses to other signals that act by initiating phospholipid
hydrolysis.